ArticleJournal of translational medicine2023

Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models.

Jessica Wenthe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.